BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ucpseguin.org//NONSGML kigkonsult.se iCalcreator 2.30.10//
CALSCALE:GREGORIAN
METHOD:PUBLISH
UID:a09afd94-0297-48d0-b8ae-5fdfda1d2f5b
X-WR-CALDESC:The Pharmacological Treatment of People with Autism and Other 
 Developmental Disabilities: A Skeptical Appraisal\n\nPsychotropic medicati
 ons are the primary tools that psychiatrists and other physicians use in t
 heir attempts to improve the behavior\, and hence the lives\, of people wi
 th autism and other developmental disabilities. Two drugs\, risperidone (R
 isperidol) and aripiprazole (Ability)\, are FDA-approved for treating “irr
 itability” in young people with autism\, and several other drugs are frequ
 ently used in off-label applications designed to benefit people with autis
 m and other developmental disabilities. Many people with developmental dis
 abilities receive psychotropic drugs and there is a substantial research l
 iterature concerning these medications. Nonetheless\, the widespread use o
 f psychotropic medications is controversial. The purpose of this workshop 
 is to provide a skeptical appraisal of the practice. Issues to be consider
  are the history of psychotropic drug use\, current practices\, research f
 indings\, and non-pharmacological alternatives and adjuncts to drug treatm
 ent. Special emphasis will be placed on the role that non-medical personne
 l can play in helping to ensure that behavior-change medications are used 
 in a way that maximally benefits people with developmental disabilities.\n
 \nAfter attending this event\, participants should be able to:\n\n1. Descr
 ibe the psychotropic drugs commonly prescribed.\n\n2. Explain the rational
 e for using those drugs\n\n3. Summarize the essential findings of research
  evaluating those drugs.\n\n4. Evaluate the quality of the researching exa
 mining drug effects.\n\n5. Explain why it is hard to compare non-pharmacol
 ogical and pharmacological interventions in a meaningful way.\n\n6. Unders
 tand potential interactions between non-pharmacological and pharmacologica
 l interventions.\n\n7. Contribute in a meaningful way to the appropriate u
 se of psychotropic drugs.
X-WR-RELCALID:d38b5625ecdead0d918237df27ad326c
X-WR-TIMEZONE:America/Chicago
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:STANDARD
TZNAME:CST
DTSTART:20181104T020000
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
RDATE:20191103T020000
RDATE:20201101T020000
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:CDT
DTSTART:20190310T020000
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
RDATE:20200308T020000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:055f64ca-937b-4779-b57d-53248ba2957d
DTSTAMP:20260515T025115Z
DESCRIPTION:The Pharmacological Treatment of People with Autism and Other D
 evelopmental Disabilities: A Skeptical Appraisal\n\nPsychotropic medicatio
 ns are the primary tools that psychiatrists and other physicians use in th
 eir attempts to improve the behavior\, and hence the lives\, of people wit
 h autism and other developmental disabilities. Two drugs\, risperidone (Ri
 speridol) and aripiprazole (Ability)\, are FDA-approved for treating “irri
 tability” in young people with autism\, and several other drugs are freque
 ntly used in off-label applications designed to benefit people with autism
  and other developmental disabilities. Many people with developmental disa
 bilities receive psychotropic drugs and there is a substantial research li
 terature concerning these medications. Nonetheless\, the widespread use of
  psychotropic medications is controversial. The purpose of this workshop i
 s to provide a skeptical appraisal of the practice. Issues to be consider 
 are the history of psychotropic drug use\, current practices\, research fi
 ndings\, and non-pharmacological alternatives and adjuncts to drug treatme
 nt. Special emphasis will be placed on the role that non-medical personnel
  can play in helping to ensure that behavior-change medications are used i
 n a way that maximally benefits people with developmental disabilities.\n
 \nAfter attending this event\, participants should be able to:\n\n1. Descr
 ibe the psychotropic drugs commonly prescribed.\n\n2. Explain the rational
 e for using those drugs\n\n3. Summarize the essential findings of research
  evaluating those drugs.\n\n4. Evaluate the quality of the researching exa
 mining drug effects.\n\n5. Explain why it is hard to compare non-pharmacol
 ogical and pharmacological interventions in a meaningful way.\n\n6. Unders
 tand potential interactions between non-pharmacological and pharmacologica
 l interventions.\n\n7. Contribute in a meaningful way to the appropriate u
 se of psychotropic drugs.
DTSTART;TZID=America/Chicago:20190729T090000
DTEND;TZID=America/Chicago:20190729T170000
LOCATION:
SUMMARY:Continuing Education Workshop
END:VEVENT
END:VCALENDAR